NCT01472380View on ClinicalTrials.gov

A Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

January 31, 2012

Conditions
Healthy
Interventions
DRUG

efavirenz

600 mg

DRUG

fenofibric acid 105 mg

fenofibric acid 105 mg

Trial Locations (1)

26505

INC Research, Morgantown

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT01472380 - A Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz | Biotech Hunter | Biotech Hunter